EcoDrugPlus

Ribosomal Protein L32

Ensembl ID : ENSCHOG00000013534
Gene Symbol: RPL32
1 Cross references
195 Possible Orthologues:

Ribosomal Protein L34

Ensembl ID : ENSCHOG00000009074
Gene Symbol: RPL34
1 Cross references
325 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSCHOG00000002277
Gene Symbol: RPL35
1 Cross references
247 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSCHOG00000007828
Gene Symbol: RPL35A
1 Cross references
239 Possible Orthologues:

Ribosomal Protein L37a

Ensembl ID : ENSCHOG00000004000
Gene Symbol: RPL37A
1 Cross references
108 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSCHOG00000003008
Gene Symbol: RPL4
1 Cross references
328 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSCHOG00000002917
Gene Symbol: RPL6
1 Cross references
424 Possible Orthologues:

Ribosomal Protein S10

Ensembl ID : ENSCHOG00000002870
Gene Symbol: RPS10
1 Cross references
283 Possible Orthologues:

Ribosomal Protein S12

Ensembl ID : ENSCHOG00000011878
Gene Symbol: RPS12
1 Cross references
361 Possible Orthologues:

Ribosomal Protein S13

Ensembl ID : ENSCHOG00000008721
Gene Symbol: RPS13
1 Cross references
304 Possible Orthologues:

Ribosomal Protein S16

Ensembl ID : ENSCHOG00000001903
Gene Symbol: RPS16
1 Cross references
268 Possible Orthologues:

Ribosomal Protein S23

Ensembl ID : ENSCHOG00000006777
Gene Symbol: RPS23
1 Cross references
243 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).